These development costs, combined with patent exclusivity that prevents generic competition until 2032, justify some premium pricing from the manufacturer's perspective
Albiglutide 30 mg was administered once weekly and enrolled a total of 9463 subjects aged 40 years with T2DM and established CVD
This approach makes medically supervised weight management accessible to middle-income families who cannot afford thousand-dollar monthly medication expenses
Following the hypothesis that GLP-1/Notch target genes most likely act redundantly, double RNAi with sygl-1 and other candidate target genes were performed (Kershner et al., 2014)
Individual results may vary depending on factors such as starting weight, dose, adherence, diet and exercise habits and how well the treatment is tolerated
This approval, granted under the expedited Commissioners National Priority Voucher (CNPV) program, brings a powerful new tool to the clinic